Skip to main content
Barbara Fisher on Muck Rack

Barbara Fisher

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Barbara

Contact Barbara, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Brain Inflammation

|
By Sayer Ji, Celeste McGovern, Jeremy Hammond Verified, Barbara Fisher
| greenmedinfo.com
Free Sample of Member-Only Features Although all 30,000+ articles on GreenMedInfo.com are made entirely free to view as an educational service to the public, we provide a powerful set of enhanced data comprehension and retrieval tools for subscribing members. Above you are viewing a free preview, limited to 10000 rows, of the membership feature called "Cumulative Knowledge" (learn more). The Focus Article Feature is not enabled.
Open in Who Shared View Duplicates (10) Issue with article?

Respiratory Diseases

|
By Jim Meehan MD, Joseph Mercola, Henry Ealy, Barbara Fisher
Free Sample of Member-Only Features Although all 30,000+ articles on GreenMedInfo.com are made entirely free to view as an educational service to the public, we provide a powerful set of enhanced data comprehension and retrieval tools for subscribing members. Above you are viewing a free preview, limited to 10000 rows, of the membership feature called "Cumulative Knowledge" (learn more). The Focus Article Feature is not enabled.
Open in Who Shared View Duplicates (71) Issue with article?

Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II Glioma | JCO Precision Oncology

|
By Jessica Fleming, Stephanie Pugh, Barbara Fisher, Glenn J. Lesser
| ascopubs.org
Abstract This study sought to determine the prognostic significance of the WHO-defined glioma molecular subgroups along with additional alterations, including MGMT promoter methylation and mutations in ATRX, CIC, FUBP1, TERT, and TP53, in NRG/RTOG 0424 using long-term follow-up data. Mutations were determined using an Ion Torrent sequencing panel. 1p/19q co-deletion and MGMT promoter methylation were determined by Affymetrix OncoScan and Illumina 450K arrays.
Open in Who Shared Issue with article?
See all 5 articles